SCHEMBL9761268

SCHEMBL9761268

NCCCCc1c(N2CCOCC2)n[nH]c1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.37
CYP2C9 P11712 5/20 0.37
ALDH1A1 P00352 6/20 0.37
CYP2C19 P33261 3/20 0.36
HTT P42858 2/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 7/20 0.34
MAPK1 P28482 3/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KMT2A Q03164 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
CYP3A4 P08684 1/20 0.33
MGMT P16455 1/20 0.33
NUDT1 P36639 1/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9761212 0.80 PARP1 (0.36) CYP1A2CYP2C9ALDH1A1CYP2C19HTT
SCHEMBL9760948 0.77 CYP1A2 (0.36) CYP1A2CYP2C9ALDH1A1CYP2C19MAPT
SCHEMBL9762223 0.76 ALDH1A1 (0.46) CYP1A2CYP2C9ALDH1A1CYP2C19HTT
SCHEMBL9761459 0.76 ALDH1A1 (0.39) CYP1A2CYP2C9ALDH1A1CYP2C19MAPT
SCHEMBL9761856 0.73 KMT2A (0.40) CYP1A2CYP2C9ALDH1A1CYP2C19HTT
SCHEMBL9761370 0.73 KDM4E (0.34) KMT2AMEN1
SCHEMBL9761621 0.70 CYP1A2 (0.39) CYP1A2CYP2C9ALDH1A1CYP2C19CYP2D6
SCHEMBL9761579 0.69 MEN1 (0.32) KMT2AMEN1
SCHEMBL9762538 0.67 SMN1; SMN2 (0.38) CYP1A2CYP2C9ALDH1A1MAPTSMN1; SMN2
SCHEMBL9761142 0.65 NPC1 (0.46) CYP1A2CYP2C9CYP2C19MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026694-A Antitumor agents THE BRITISH COLUMBIA CANCER FOUNDATION (CA) 1991-06-25 US disclosed